Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.

Saved in:
Bibliographic Details
Title: Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.
Authors: Wilkinson AL; US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lxq6@cdc.gov., Zaman K; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Hoque M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Estivariz CF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Burns CC; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Konopka-Anstadt JL; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Mainou BA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Kovacs SD; US Centers for Disease Control and Prevention, Atlanta, GA, USA., An Q; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Lickness JS; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Yunus M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Snider CJ; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Zhang Y; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Coffee E; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Abid T; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Wassilak SGF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Pallansch MA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Oberste MS; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Vertefeuille JF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Anand A; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Sep; Vol. 23 (9), pp. 1062-1071. Date of Electronic Publication: 2023 May 10.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Equivalence Trial
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37178706
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wilkinson+AL%22">Wilkinson AL</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lxq6@cdc.gov.<br /><searchLink fieldCode="AU" term="%22Zaman+K%22">Zaman K</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Hoque+M%22">Hoque M</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Estivariz+CF%22">Estivariz CF</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Burns+CC%22">Burns CC</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Konopka-Anstadt+JL%22">Konopka-Anstadt JL</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Mainou+BA%22">Mainou BA</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kovacs+SD%22">Kovacs SD</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22An+Q%22">An Q</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Lickness+JS%22">Lickness JS</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Yunus+M%22">Yunus M</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Snider+CJ%22">Snider CJ</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Coffee+E%22">Coffee E</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Abid+T%22">Abid T</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Wassilak+SGF%22">Wassilak SGF</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Pallansch+MA%22">Pallansch MA</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Oberste+MS%22">Oberste MS</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Vertefeuille+JF%22">Vertefeuille JF</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Anand+A%22">Anand A</searchLink>; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2023 Sep; Vol. 23 (9), pp. 1062-1071. <i>Date of Electronic Publication: </i>2023 May 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Equivalence Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37178706
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1473-3099(23)00139-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1062
    Titles:
      – TitleFull: Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wilkinson AL
      – PersonEntity:
          Name:
            NameFull: Zaman K
      – PersonEntity:
          Name:
            NameFull: Hoque M
      – PersonEntity:
          Name:
            NameFull: Estivariz CF
      – PersonEntity:
          Name:
            NameFull: Burns CC
      – PersonEntity:
          Name:
            NameFull: Konopka-Anstadt JL
      – PersonEntity:
          Name:
            NameFull: Mainou BA
      – PersonEntity:
          Name:
            NameFull: Kovacs SD
      – PersonEntity:
          Name:
            NameFull: An Q
      – PersonEntity:
          Name:
            NameFull: Lickness JS
      – PersonEntity:
          Name:
            NameFull: Yunus M
      – PersonEntity:
          Name:
            NameFull: Snider CJ
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Coffee E
      – PersonEntity:
          Name:
            NameFull: Abid T
      – PersonEntity:
          Name:
            NameFull: Wassilak SGF
      – PersonEntity:
          Name:
            NameFull: Pallansch MA
      – PersonEntity:
          Name:
            NameFull: Oberste MS
      – PersonEntity:
          Name:
            NameFull: Vertefeuille JF
      – PersonEntity:
          Name:
            NameFull: Anand A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2023 Sep
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1474-4457
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: The Lancet. Infectious diseases
              Type: main
ResultId 1